NURECA2025-07-012025-09-30NURECA2025-09-30NURECA2025-03-31NURECA2025-04-012025-09-30NURECA2025-07-012025-09-30in-capmkt:OtherExpenses1MemberNURECA2025-04-012025-09-30in-capmkt:OtherExpenses1MemberNURECA2025-07-012025-09-30RelatedPartyTransactionDomain1NURECA2025-06-30RelatedPartyTransactionDomain1NURECA2025-09-30RelatedPartyTransactionDomain1NURECA2025-07-012025-09-30RelatedPartyTransactionDomain2NURECA2025-06-30RelatedPartyTransactionDomain2NURECA2025-09-30RelatedPartyTransactionDomain2NURECA2025-07-012025-09-30RelatedPartyTransactionDomain3NURECA2025-06-30RelatedPartyTransactionDomain3NURECA2025-09-30RelatedPartyTransactionDomain3NURECA2025-07-012025-09-30RelatedPartyTransactionDomain4NURECA2025-06-30RelatedPartyTransactionDomain4NURECA2025-09-30RelatedPartyTransactionDomain4NURECA2025-07-012025-09-30RelatedPartyTransactionDomain5NURECA2025-06-30RelatedPartyTransactionDomain5NURECA2025-09-30RelatedPartyTransactionDomain5NURECA2025-07-012025-09-30RelatedPartyTransactionDomain6NURECA2025-06-30RelatedPartyTransactionDomain6NURECA2025-09-30RelatedPartyTransactionDomain6NURECA2025-07-012025-09-30RelatedPartyTransactionDomain7NURECA2025-06-30RelatedPartyTransactionDomain7NURECA2025-09-30RelatedPartyTransactionDomain7NURECA2025-07-012025-09-30RelatedPartyTransactionDomain8NURECA2025-06-30RelatedPartyTransactionDomain8NURECA2025-09-30RelatedPartyTransactionDomain8NURECA2025-07-012025-09-30RelatedPartyTransactionDomain9NURECA2025-06-30RelatedPartyTransactionDomain9NURECA2025-09-30RelatedPartyTransactionDomain9NURECA2025-07-012025-09-30RelatedPartyTransactionDomain10NURECA2025-06-30RelatedPartyTransactionDomain10NURECA2025-09-30RelatedPartyTransactionDomain10NURECA2025-07-012025-09-30RelatedPartyTransactionDomain11NURECA2025-06-30RelatedPartyTransactionDomain11NURECA2025-09-30RelatedPartyTransactionDomain11NURECA2025-07-012025-09-30RelatedPartyTransactionDomain12NURECA2025-06-30RelatedPartyTransactionDomain12NURECA2025-09-30RelatedPartyTransactionDomain12NURECA2025-07-012025-09-30RelatedPartyTransactionDomain13NURECA2025-06-30RelatedPartyTransactionDomain13NURECA2025-09-30RelatedPartyTransactionDomain13NURECA2025-07-012025-09-30RelatedPartyTransactionDomain14NURECA2025-06-30RelatedPartyTransactionDomain14NURECA2025-09-30RelatedPartyTransactionDomain14NURECA2025-07-012025-09-30RelatedPartyTransactionDomain15NURECA2025-06-30RelatedPartyTransactionDomain15NURECA2025-09-30RelatedPartyTransactionDomain15NURECA2025-07-012025-09-30RelatedPartyTransactionDomain16NURECA2025-06-30RelatedPartyTransactionDomain16NURECA2025-09-30RelatedPartyTransactionDomain16NURECA2025-07-012025-09-30RelatedPartyTransactionDomain17NURECA2025-06-30RelatedPartyTransactionDomain17NURECA2025-09-30RelatedPartyTransactionDomain17NURECA2025-07-012025-09-30RelatedPartyTransactionDomain18NURECA2025-06-30RelatedPartyTransactionDomain18NURECA2025-09-30RelatedPartyTransactionDomain18NURECA2025-07-012025-09-30RelatedPartyTransactionDomain19NURECA2025-06-30RelatedPartyTransactionDomain19NURECA2025-09-30RelatedPartyTransactionDomain19NURECA2025-07-012025-09-30RelatedPartyTransactionDomain20NURECA2025-06-30RelatedPartyTransactionDomain20NURECA2025-09-30RelatedPartyTransactionDomain20NURECA2025-07-012025-09-30RelatedPartyTransactionDomain21NURECA2025-06-30RelatedPartyTransactionDomain21NURECA2025-09-30RelatedPartyTransactionDomain21NURECA2025-07-012025-09-30RelatedPartyTransactionDomain22NURECA2025-06-30RelatedPartyTransactionDomain22NURECA2025-09-30RelatedPartyTransactionDomain22NURECA2025-07-012025-09-30RelatedPartyTransactionDomain23NURECA2025-06-30RelatedPartyTransactionDomain23NURECA2025-09-30RelatedPartyTransactionDomain23NURECA2025-07-012025-09-30RelatedPartyTransactionDomain24NURECA2025-06-30RelatedPartyTransactionDomain24NURECA2025-09-30RelatedPartyTransactionDomain24NURECA2025-07-012025-09-30RelatedPartyTransactionDomain25NURECA2025-06-30RelatedPartyTransactionDomain25NURECA2025-09-30RelatedPartyTransactionDomain25NURECA2025-07-012025-09-30RelatedPartyTransactionDomain26NURECA2025-06-30RelatedPartyTransactionDomain26NURECA2025-09-30RelatedPartyTransactionDomain26NURECA2025-07-012025-09-30RelatedPartyTransactionDomain27NURECA2025-06-30RelatedPartyTransactionDomain27NURECA2025-09-30RelatedPartyTransactionDomain27NURECA2025-07-012025-09-30AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares543264NURECANOTLISTEDINE0DSF01015NURECA LIMITEDMain BoardEquity2025-04-012026-03-312025-10-162025-10-09INRMillionsQuarterlySecond quarterSingle segmentHome Healthcare and Wellness Products2025-10-1616:00:002025-10-1617:15:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2025-01-24https://www.nureca.com/wp-content/uploads/2021/07/Policy%20for%20consideration%20and%20approval%20of%20related%20party%20transactions%20effective%20from%20April%2001%2C%202022.pdf?_t=1646311307falsefalseNo default2025-07-012025-09-30UnauditedStandalone378410000238100004022200000249170000952000037940000410000048200005560000036115000041070000041070000096700009670000031400000000031400000031400000100000000103.143.14003.143.142025-04-012025-09-30UnauditedStandalone721650000497300007713800000503030000-740000787200006120000961000012524000072198000049400000049400000200001247000012490000036910000000036910000036910000100000000103.693.69003.693.69Other Expenses55600000Other Expenses12524000096880000000353000000003046000000131150000161610000212700001983000033489000035882000075480000830400001130000012000032300001146130000131930000001189200001797040000002131930000100000000186170000019617000001961700000449000000095300001402000082800000002230000042700002390000930700009546000022510000122240000231000002590000001479300000017023000021319300006120000-3340000-1966000001630000000-3100000440400000982000009610000021600000-58700000-51200000411100000-2800000-9300000-16000001127000060670000000551000005516000000000000417000053320000000000000000002950000000691200000-85930000-6301000000000000064700001400000612000000-12730000-205800000-205800003188000011300000Nureca Limited******Nureca Technologies Private Limited******Wholly Owned SubsidiarySale of goods or services130000000Audit Committee approval has been received, no special remarks.14500002025-05-05249000000Nureca Limited******Nureca Technologies Private Limited******Wholly Owned SubsidiaryPurchase of goods or services500000000Audit Committee approval has been received, no special remarks.40900002025-05-0514331000034600003100000Nureca Limited******Nureca INC******Wholly Owned SubsidiaryAny other transactionReimbursement of expenses paid by the companyAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.100002025-05-053300002320000260000Nureca Limited******Nureca Technologies Private Limited******Wholly Owned SubsidiaryAny other transactionReimbursement of expenses paid by the companyAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.28000000Nureca Limited******Nureca Technologies Private Limited******Wholly Owned SubsidiaryLoan100000000Board approval has been received.No special Remarks-300000061600003160000Loan0.083UnsecuredWorking Capital requirementNureca Limited******Nureca Healthcare Private Limited******Wholly Owned SubsidiaryLoan300000Board approval has been received.No special Remarks000Loan0.083UnsecuredWorking Capital requirementNureca Limited******Nureca Technologies Private Limited******Wholly Owned SubsidiaryAny other transactionSecurity deposit against property rented110000Audit Committee approval has been received, no special remarks.0110000110000Nureca Limited******Nureca Technologies Private Limited******Wholly Owned SubsidiaryAny other transactionFee charged on corporate guarantee givenAudit Committee approval has been received, no special remarks.39000000Nureca Limited******Mr. Saurabh Goyal******Managing DirectorRemunerationAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.15000002025-05-0590000002470000960000Nureca Limited******Ms. Payal Goyal******Relatives of KMPsRemunerationAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.11400002025-05-0568400001210000780000Nureca Limited******Mr. Aryan Goyal******Chief Executive OfficerRemunerationAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.15000002025-05-0590000002090000960000Nureca Limited******Mr. Naresh Gupta******Chief Financial OfficerRemunerationAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.3400002025-05-052070000340000340000Nureca Limited******Ms. Nishu Kansal******Company SecretaryRemunerationAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.1300002025-05-05790000130000130000Nureca Limited******Mr. Rajinder Sharma******Executive DirectorRemunerationAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.300002025-05-051500003000030000Nureca Limited******Mr. Vijay Kumar Sharma******Independent DirectorAny other transactionSitting feeAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.30000000Nureca Limited******Ms. Ruchita Agarwal******Independent DirectorAny other transactionSitting feeAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.4000000Nureca Limited******Ms. Charu Singh******Independent DirectorAny other transactionSitting feeAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.4000000Nureca Limited******Mr. Vikram Chaudhery******Independent DirectorAny other transactionSitting feeAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.000Nureca Limited******Mr. Rupinder Tiwari******Independent DirectorAny other transactionSitting feeAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.3000000Nureca Limited******Mr. K.K. Bhasin******Independent DirectorAny other transactionSitting feeAudit Committee approval has been received on all perpetual transactions for the term of managerial remuneration/salary to KMPs/sitting fees/ reimbursement of expenses. Further approval of audit committee/board has been seen as per the provision of the Companies Act.3000000Nureca Limited******Nureca Healthcare Private Limited******Wholly Owned SubsidiaryAny other transactionRent IncomeAudit Committee approval has been received.No special Remarks-30000300000Nureca Limited******Nureca Technologies Private Limited******Wholly Owned SubsidiaryAny other transactionRent IncomeAudit Committee approval has been received.No special Remarks83000000Nureca Limited******Nureca INC******Wholly Owned SubsidiaryInvestmentNo transaction during the period0460000460000Nureca Limited******Nureca Healthcare Private Limited******Wholly Owned SubsidiaryInvestmentNo transaction during the period-1000001000000Nureca Limited******Nureca Technologies Private Limited******Wholly Owned SubsidiaryInvestmentNo transaction during the period03000000030000000Nureca Limited******Nureca Technologies Private Limited******Wholly Owned SubsidiaryAny other transactionInterest on borrowing given100000000Board approval has been received.No special Remarks18000000Nureca Limited******Nureca Healthcare Private Limited******Wholly Owned SubsidiaryAny other transactionInterest on borrowing given100000000Board approval has been received.No special Remarks-20000200000172950000UnauditedtrueSinghi and Companytrue2028-08-31